{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42166306-semaglutide:v1","objectPathId":"pubmed-pmid-42166306-semaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42166306-semaglutide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42166306-semaglutide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42166306-semaglutide-v1.md"},"story":{"slug":"pubmed-pmid-42166306-semaglutide","version":1,"domain":"Literature metadata","dateInSource":"2026-07-17","sourceCheckedAt":"2026-08-10","publishedAt":"2026-08-13","peptideSlugs":["semaglutide"],"peptides":[{"slug":"semaglutide","url":"https://peptidescanner.com/peptides/semaglutide/"}]},"claims":[{"id":"headline","text":"Real-world use of semaglutide for obesity treatment: A cohort study in an integrated health care delivery system.","sourceIds":["pubmed-observation-pmid-42166306-2026-07-17-2eacf6296f80"]},{"id":"summary","text":"PubMed lists PMID 42166306 in Journal of managed care & specialty pharmacy as Journal Article, Observational Study, with publication-date metadata of 2026-06 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42166306-2026-07-17-2eacf6296f80"]},{"id":"paragraph-1","text":"PubMed lists PMID 42166306 in Journal of managed care & specialty pharmacy as Journal Article, Observational Study, with publication-date metadata of 2026-06 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42166306-2026-07-17-2eacf6296f80"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42166306-2026-07-17-2eacf6296f80"]}],"sources":[{"id":"pubmed-observation-pmid-42166306-2026-07-17-2eacf6296f80","name":"PubMed","sourceClass":"A","title":"Real-world use of semaglutide for obesity treatment: A cohort study in an integrated health care delivery system. · retained source version 1:2026-07-17:current:2eacf6296f80723422e69ea69f8258fa20cfa7ccbe241af69354c66d9df6b4ca","url":"https://pubmed.ncbi.nlm.nih.gov/42166306/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"10af42154662b9fb95ceee2f1d27d042403ce334cc75b468492afc68977d15d3","tierARecordSha256":"a33d557e6c8a9afed4051308898b9fa0cf312a347e145715e3d41389a8e5c115"},"integrity":{"algorithm":"sha256","contentSha256":"57e60477b0e7ea1b2cb388727bae50efaa69e9eec2808c7ad72fc148e6fa6694"}}